The data associated with this publication are not available for this reason: N/A
Abstract
Traumatic Brain Injury (TBI) is a major source of mortality worldwide. Survivors of moderate-to-severe TBI frequently have neurological and cognitive deficits. There are no pharamacological therapeutics for neuroprotection following TBI.
